The βAPP717 Alzheimer mutation increases the percentage of plasma amyloid-β protein ending at Aβ42(43)

Neurology

Volumn 48, Issue 3, 1997, Pages 741-745

  Kosaka, T ^a,b   Imagawa, M ^c   Seki, K ^d   Arai, H ^e   Sasaki, H ^e   Tsuji, S ^f   Asami Odaka, A ^b   Fukushima, T ^a   Imai, K ^a   Iwatsubo, Takeshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^c HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^d Mishima Hospital   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ISOLEUCINE; VALINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN METABOLISM; SENILE PLAQUE;

EID: 0030897134     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.3.741     Document Type: Article

References (29)

1. Selkoe DJ. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 1994;10:373-403.
2. Haass C, Schlossmacher MG, Hung AY, et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 1992;359:322-325.
3. Seubert P, Vigo-Pelfrey C, Esch F, et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 1992;359:325-327.
4. Shoji M, Golde TE, Ghiso J, et al. Production of the Alzheimer amyloid βprotein by normal proteolytic processing. Science 1992;258:126-129.
5. Suzuki N, Cheung TT, Cai X-D, et al. An increased percentage of long amyloid β-protein is secreted by familial amyloid β-protein precursor (βAPP717) mutants. Science 1994;264: 1336-1340.
6. Jarrett JT, Berger EP, Lansbury PT Jr. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993;32:4693-4697.
7. Iwatsubo T, Odaka A, Suzuki N, et al. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 1994;13:45-53.
8. Iwatsubo T, Mann DMA, Odaka A, et al. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann Neurol 1995;37:294-299.
9. Teller JK, Russo C, DeBusk LM, et al. Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down's syndrome. Nat Med 1996;2:93-95.
10. Mullan M, Crawford F, Axelman K, et al. A pathogenetic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat Genet 1992;1:345-347.
11. Goate A, Chartier-Harlin M-C, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.
12. Citron M, Oltersdolf T, Haass C, et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 1992;360:672-674.
13. Cai X-D, Golde TE, Younkin SG. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 1993;259:514-516.
14. Tamaoka A, Odaka A, Ishibashi Y, et al. APP717 missense mutation affects the ratio of amyloid β protein species (Aβ1-42/43 and Aβ1-40) in familial Alzheimer's disease. J Biol Chem 1994;269:32721-32724.
15. 717 of amyloid precursor protein are specific for the increased secretion of Aβ42(43). Biochem Biophys Res Comm 1996;227:730-735.
16. Younkin SG. Evidence that Aβ42 is the real culprit in Alzheimer's disease. Ann Neurol 1995;37:287-288.
17. Naruse S, Igarashi S, Kobayashi H, et al. Mis-sense mutation Val to Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 1991;337:978-979.
18. Imagawa M, Naruse S, Tsuji S, et al. Coenzyme Q10, iron, and vitamin B6 in genetically confirmed Alzheimer's disease. Lancet 1992;340:671.
19. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
20. Berg L, Hughes CP, Coben LA, et al. Mild senile dementia of Alzheimer type: research diagnostic criteria, recruitment, and description of a study population. J Neurol Neurosurg Psychiatry 1982;45:962-968.
21. Arai H, Terajima M, Miura M, et al. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann Neurol 1995;38:649-652.
22. Asami-Odaka A, Ishibashi Y, Kikuchi T, et al. Long amyloid β-protein secreted from wild-type human neuroblastoma IMR-32. Biochemistry 1995;34:10272-10278.
23. Scheuner D, Eckman C, Jensen M, et al. The amyloid β protein deposited in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996;2:864-871.
24. Vigo-Pelfrey C, Lee D, Keim, P. et al. Characterization of β-amyloid peptide from human cerebrospinal fluid. J Neurochem 1993;61:1965-1968.
25. Chen M, Inestrosa NC, Ross GS, Fernandez HL. Platelets are the primary source of amyloid β-peptide in human blood. Biochem Biophys Res Commun 1995;213:96-103.
26. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995;373:523-527.
27. Motter R, Vigo-Pelfrey C, Kholodenko D, et al. Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 1995;38:643-648.
28. Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease Nature 1995;375:754-760.
29. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-977.